Rick Wagner, Ph.D.
President and CEO
Rick Wagner, Ph.D., is the founder of X-Chem, Inc., X-Rx, Inc., and X-BODY Biosciences. Wagner currently serves as interim president and chief executive officer of X-Rx, and chief executive officer and president of X-Chem .
Jeffrey Troderman, CPA, MBA
Chief Financial Officer
Jeff Troderman has more than 25 years of financial management and consulting experience culminating in his current position as Chief Financial Officer of X-Rx, Inc. Prior to joining X-Rx, Jeff spent nearly 15 years as a principal at two regional consulting firms where he served as interim CFO for a broad client base, including many life science companies.
Director of Project Management
Julie Robey, Director of Project Management, has more than 20 years of data management, clinical management and project management experience across multiple indications in Phase I-IV studies.
Ed Koval, MBA
Chief Business Officer
Ed Koval is serving as the Chief Business Officer for X-Rx. Koval also serves as the Sr. Vice President of Corporate Development for X-Chem and brings more than 20 years of strategy, business / corporate development and finance experience to the company.
Terry Loding, MBA
Chief Operating Officer
Terry Loding is serving as the Chief Operating Officer for X-Rx. Loding also serves as the Sr. Vice President of Corporate Strategy and Alliances for X-Chem and brings more than 20 years of clinical operations, alliance management, business development and strategy to the company.